间充质干细胞
医学
脊髓损伤
骨髓
干细胞
外科
脊髓
病理
生物
细胞生物学
精神科
作者
Ying-Chuan Kuan,Shinn‐Zong Lin,Tsung‐Lang Chiu,Hsiang‐Yi Hung
出处
期刊:Regenerative Medicine
[Future Medicine]
日期:2015-10-01
卷期号:18 (12): 907-911
被引量:3
标识
DOI:10.2217/rme-2023-0120
摘要
Aim: Spinal cord injury (SCI) can cause severe disability. Several clinical trials of stem-cell based therapies are ongoing. We describe our experience of bone marrow mesenchymal stem cell (BMSC) therapy in a patient with complete SCI in the chronic stage. Case report: A 25-year-old man with complete SCI at T6 level presented with paraplegia for 5 years. We transplanted autologous BMSCs intramedullary. After 12 months follow-up, his Barthel index score was noticeably improved from severe to moderate dependency, and the sensation level improved from T7 to S5, but no improvement of motor function. Conclusion: Autologous BMSCs are potentially safe for patients with complete SCI in the chronic stage and may improve neurological function and quality of life.
科研通智能强力驱动
Strongly Powered by AbleSci AI